Terms: = Lung cancer AND BCL2, Bcl-2, 596, ENSG00000171791 AND Treatment
1549 results:
1. Juglone triggers apoptosis of non-small cell lung cancer through the reactive oxygen species -mediated PI3K/Akt pathway.
Zhong J; Hua Y; Zou S; Wang B
PLoS One; 2024; 19(5):e0299921. PubMed ID: 38814975
[TBL] [Abstract] [Full Text] [Related]
2. Evaluation of sex inequity in lung-cancer-specific survival.
Lærum D; Strand TE; Brustugun OT; Gallefoss F; Falk R; Durheim MT; Fjellbirkeland L
Acta Oncol; 2024 May; 63():343-350. PubMed ID: 38751329
[TBL] [Abstract] [Full Text] [Related]
3. Hederagenin promotes lung cancer cell death by activating CHAC1-dependent ferroptosis pathway.
Lu J; Guo Q; Zhao H; Liu H
Biochem Biophys Res Commun; 2024 Jul; 718():150085. PubMed ID: 38735142
[TBL] [Abstract] [Full Text] [Related]
4. QiDongNing induces lung cancer cell apoptosis via triggering P53/DRP1-mediated mitochondrial fission.
Ding R; Wang Y; Xu L; Sang S; Wu G; Yang W; Zhang Y; Wang C; Qi A; Xie H; Liu Y; Dai A; Jiao L
J Cell Mol Med; 2024 May; 28(9):e18353. PubMed ID: 38682742
[TBL] [Abstract] [Full Text] [Related]
5. Transitioning to a Personalized Approach in Molecularly Subtyped Small-Cell lung cancer (SCLC).
Grenda A; Krawczyk P; Obara A; Gajek Ł; Łomża-Łaba A; Milanowski J
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673793
[TBL] [Abstract] [Full Text] [Related]
6. The impact of social support on benefit finding among patients with advanced lung cancer and their caregivers: based on actor-partner interdependence mediation model.
Zhao M; Na N; Xing N; Zhu H; Wu G; Xu G; Jiang Y
Support Care Cancer; 2024 Apr; 32(5):287. PubMed ID: 38619660
[TBL] [Abstract] [Full Text] [Related]
7. [Effect of CircCCND1 on the Malignant Biological Behaviors of H446 lung cancer Cells by Regulating the MiR-340-5p/TGIF1 Axis].
Dong Y; Zhu C; Liu X; Zhao J; Li Q
Zhongguo Fei Ai Za Zhi; 2024 Mar; 27(3):161-169. PubMed ID: 38590190
[TBL] [Abstract] [Full Text] [Related]
8. Babaodan overcomes cisplatin resistance in cholangiocarcinoma via inhibiting YAP1.
Li J; Ma X; Xu F; Yan Y; Chen W
Pharm Biol; 2024 Dec; 62(1):314-325. PubMed ID: 38571483
[TBL] [Abstract] [Full Text] [Related]
9. Galectin-1 overexpression induces normal fibroblasts translate into cancer-associated fibroblasts and attenuates the sensitivity of anlotinib in lung cancer.
Zhang L; Chen W; Li X; Wang G; Xing F; Zhu X
Cell Adh Migr; 2024 Dec; 18(1):1-11. PubMed ID: 38557441
[TBL] [Abstract] [Full Text] [Related]
10. Reduced dose azacitidine plus venetoclax as maintenance therapy in acute myeloid leukaemia following intensive or low-intensity induction: a single-centre, single-arm, phase 2 trial.
Bazinet A; Kantarjian H; Bataller A; Pemmaraju N; Borthakur G; Chien K; Alvarado Y; Bose P; Jabbour E; Yilmaz M; DiNardo C; Issa G; Montalban-Bravo G; Short N; Sasaki K; Bull-Linderman D; Daver N; Garcia-Manero G; Ravandi F; Kadia T
Lancet Haematol; 2024 Apr; 11(4):e287-e298. PubMed ID: 38548404
[TBL] [Abstract] [Full Text] [Related]
11. Noscapine and Apoptosis in Breast and Other cancers.
Calaf GM; Crispin LA; Quisbert-Valenzuela EO
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542508
[TBL] [Abstract] [Full Text] [Related]
12. Recent advances in the therapeutic potential of nobiletin against respiratory diseases.
Qin Y; Yang J; Li H; Li J
Phytomedicine; 2024 Jun; 128():155506. PubMed ID: 38522319
[TBL] [Abstract] [Full Text] [Related]
13. Suppression of NSCLC progression via the co-administration of Danusertib, an AURK inhibitor, and KRIBB11, an HSF1 inhibitor.
Zhang X; Lei Y; Chen X; He J; Liu Z; Zhu W; Xu Y; Jin X
Biochem Pharmacol; 2024 May; 223():116155. PubMed ID: 38521474
[TBL] [Abstract] [Full Text] [Related]
14. Synergistic effect of cannabidiol with dasatinib on lung cancer by SRC/PI3K/AKT signal pathway.
Ye Q; Gui C; Jin D; Zhang J; Zhang J; Ma N; Xu L
Biomed Pharmacother; 2024 Apr; 173():116445. PubMed ID: 38503236
[TBL] [Abstract] [Full Text] [Related]
15. [Demethylzeylasteral inhibits proliferation, migration and invasion and promotes apoptosis of non-small cell lung cancer cells by inhibiting the AKT/CREB signaling pathway].
Han Q; Ye M; Jin Q
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Feb; 44(2):280-288. PubMed ID: 38501413
[TBL] [Abstract] [Full Text] [Related]
16. Clinical Characteristics, Management and Prognostic Factors of Immune Checkpoint Inhibitor-Associated Pneumonia in Chinese cancer Patients.
Li J; Chen S; Yan T; Zeng M
J Coll Physicians Surg Pak; 2024 Mar; 34(3):302-307. PubMed ID: 38462865
[TBL] [Abstract] [Full Text] [Related]
17. YES1 as a potential target to overcome drug resistance in EGFR-deregulated non-small cell lung cancer.
Kook E; Lee J; Kim DH
Arch Toxicol; 2024 May; 98(5):1437-1455. PubMed ID: 38443724
[TBL] [Abstract] [Full Text] [Related]
18. Highly in vitro anti-cancer activity of melittin-loaded niosomes on non-small cell lung cancer cells.
Honari P; Shahbazzadeh D; Behdani M; Pooshang Bagheri K
Toxicon; 2024 Apr; 241():107673. PubMed ID: 38432612
[TBL] [Abstract] [Full Text] [Related]
19. [Mechanism of n-butanol fraction of Wenxia Formula combining with gefitinib in treating non-small cell lung cancer based on network pharmacology and in vitro experiment].
Chen RJ; Bi QY; Shi JM; Zhong J; Han JT; Ji XM
Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(2):471-486. PubMed ID: 38403323
[TBL] [Abstract] [Full Text] [Related]
20. Synthesis and In Vitro Antitumor Activity Evaluation of Gefitinib-1,2,3-Triazole Derivatives.
Liu Z; Liu J; Gao E; Mao L; Hu S; Li S
Molecules; 2024 Feb; 29(4):. PubMed ID: 38398589
[TBL] [Abstract] [Full Text] [Related]
[Next]
